Objectives The global prevalence of Parkinsonism continues to rise given ageing
populations. Individuals with Parkinsonism who have moderate or severe symptoms …

The annual incidence of tumors of the central nervous system (CNS) is little over 22 per 100
000 in the general population (1). Around a third of these lesions are malignant. Among the …

The aim of this study was to establish preliminary quantitative evidence for the longitudinal
change in family function, perceived support, and caregiver burden, acknowledging that …

Purpose Primary brain tumor (PBT) patients report sleep disturbance due to their disease
and treatment, yet few studies have utilized validated measures to understand the extent of …

Background Fatigue is a common symptom in patients with brain tumors, but comprehensive
studies on fatigue in patients with meningioma specifically are lacking. This study examined …

Background Sleep disturbance (SD) is common in patients with cancer and has been
associated with worse clinical outcomes. This cross-sectional study explored the prevalence …

Background Emerging evidence supports the clinical impact of sleep disturbance (SD) on
cancer patients. This study aimed to determine the prevalence and predictors of SD in …

There is an association between sleep quality and glioma-specific outcomes, including
survival. The critical role of sleep in survival among subjects with glioma may be due to …

Background Sleep disturbances are highly prevalent in patients treated for a primary brain
tumor, with reported prevalence estimates ranging between 30 and 50%[Citation 1–3] …

Sleep is one of the most important aspects of the normal functioning of the brain and the
entire organism. Research into the different ways in which sleep can be disrupted as well as …